For moderate to severe ulcerative colitis (UC) in adult TNFi-IR patients.1

ABBVIE'S
COMMITMENT TO

E XC EP T I O N A L

ACCESS & PATIENT
SUPPORT

Get started with the Enrollment
and Prescription Form 

IR=intolerance or inadequate response;
TNFi=tumor necrosis factor inhibitor

Commercial access

Working Towards 100%
Commercial Coverage*

Broader coverage*† is available
for your patients.
Find commercial insurance plans
for RINVOQ in your area.

ENCOURAGE YOUR
PATIENTS TO ENROLL IN

RINVOQ® Complete

One-To-One
Support

Nurse Ambassadors and
Access Specialists provide
1-to-1 support to help
navigate insurance.

Affordability

Eligible commercially-insured
patients pay as little as $5 per month
on their prescription and can be reimbursed for the out-of-pocket costs of related lab tests and monitoring.§

Zero dollar

Access

No charge for eligible patients
experiencing initial insurance denial
for up to 24 months.

Streamlined
Enrollment Process

Get started with a single enrollment form.

Patients who are uninsured, or who are otherwise unable to pay for their medication, may be eligible for:

myAbbVie Assist | Patient Assistance

*Formulary Definitions: Preferred means the product name is placed on the plan's preferred formulary. Based on formulary status under the pharmacy benefit.

Coverage requirements and benefit designs vary by payer and may change over time. Please consult with payers directly for the most current reimbursement policies.

Nurse Ambassadors are provided by AbbVie and do not provide medical advice or work under the direction of the prescribing health care professional (HCP). They are trained to direct patients to speak with their HCP about any treatment-related questions, including further referrals.

§RINVOQ® Complete: Terms and Conditions apply: This benefit covers RINVOQ® (upadacitinib) alone or for RINVOQ plus one of the following medications: methotrexate, leflunomide, or hydroxychloroquine. Benefit also covers certain lab tests to monitor for specific parameters as recommended in the product label where the full cost is not covered by patients' insurance through the Complete Rebate program (maximum savings limit applies). Eligibility: Available to patients with commercial prescription insurance coverage for RINVOQ who meet eligibility criteria. Co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance program (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient's health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the RINVOQ Complete Savings Card and patient must call RINVOQ Complete at 1.800.2RINVOQ to stop participation. Patients residing in or receiving treatment in certain states may not be eligible. Patients may not seek reimbursement for value received from the RINVOQ Complete program from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. Patients who are members of insurance plans that claim to reduce or eliminate their patients' out of pocket co-pay, co-insurance, or deductible obligations for certain prescription drugs based upon the availability of, or patient's enrollment in, manufacturer sponsored copay assistance for such drugs (often terms "maximizer" programs) will have an annual maximum program benefit of $6,000.00 per calendar year. This assistance offer is not health insurance. To learn about AbbVie's privacy practices and your privacy choices, visit
www.abbvie.com/privacy.html

||Eligibility criteria: Available to patients aged 63 or younger with commercial insurance coverage. Patients must have a valid prescription for RINVOQ® (upadacitinib) for an FDA approved indication and a denial of insurance coverage based on a prior authorization request on file along with a confirmation of appeal. Continued eligibility for the program requires the submission of an appeal of the coverage denial every 180 days. Program provides for RINVOQ® (upadacitinib) at no charge to patients for up to two years or until they receive insurance coverage approval, whichever occurs earlier, and is not contingent on purchase requirements of any kind. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state program. Offer subject to change or discontinuance without notice. This is not health insurance and program does not guarantee insurance coverage. No claims for payment may be submitted to any third party for product dispensed by program. Limitations may apply.

RINVOQ® Complete program

SUPPORTING PATIENTS
TOGETHER

AbbVie offers COMPLETE Patient Support Programs with Specialists who provide 1-to-1 support to help patients throughout their prescribed treatment plan.

ACCESS

Dedicated specialists to assist with timely and affordable access to treatment

START

Helping patients access the resources they need, when they need them

STAY

Continuing support to help avoid potential treatment disruptions

How to enroll patients

HOW TO ENROLL PATIENTS
IN THE COMPLETE PROGRAM

Help patients get the support they
need to
start and stay on track with
their prescribed treatment.

1

Fill out the form with your patient

This form enrolls your patient and can be used
to initiate a prescription with your patient’s
preferred specialty pharmacy.

2

Fill out the patient support prescription
in Section 7

This may help your commercially insured
patients get access to RINVOQ if they
experience a delay or denial in their
insurance coverage.*

3

Fax the form to 1-678-727-0690

You will receive a call from an Access Specialist
to discuss next steps. If using the Pharmacy
Prescription in Section 6, fax a copy to your
patient’s specialty pharmacy as well.

4

Inform your patient that they have been
enrolled

Let your patient know that they will be receiving
a call from their Nurse Ambassador.†

GET STARTED WITH
THE ENROLLMENT &
PRESCRIPTION FORM

*Program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], MedicareAdvantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be eligible to participate in program. Available to patients between the ages of 18-63 with commercial prescription insurance coverage who meet eligibility criteria. Eligibility: Patients must be diagnosed with moderate to severe ulcerative colitis, have a valid prescription for RINVOQ® and participate in a commercial insurance plan that has denied or not yet made a formulary decision for RINVOQ. Once the patient’s insurance plan has made a formulary decision and established a process for reviewing coverage requests for RINVOQ, continued eligibility for the program requires the submission of a Prior Authorization prior to the next scheduled dose and appeal of the coverage denial within 180 days. Program provides RINVOQ at no charge to patients for up to 2 years or until they receive insurance coverage approval, whichever occurs earlier. Offer subject to change or discontinuance without notice. This is not health insurance and program does not guarantee insurance coverage.

Nurse Ambassadors are provided by AbbVie and do not provide medical advice or work under the direction of the prescribing healthcare professional (HCP). They are trained to direct patients to speak with their HCP about any treatment-related questions, including further referrals.

COMPLETE APP

Track treatment

The Complete App helps patients stay on track
with their prescribed RINVOQ treatment by
helping them:

  • Access additional resources, including a
    savings card for those who are eligible
  • Set up medication reminders
  • Log symptoms
  • Log medication lot number and medication
    expiration date

COMPLETEPRO.COM

Streamline the Rx process

CompletePro.com enables seamless enrollment in
RINVOQ Complete and helps streamline the
prescription process for your patients.

 

With CompletePro.com, you can:

  • Request benefits verifications
  • Complete and submit prior authorizations
  • Send prescriptions to the patient’s specialty
    pharmacy of choice, with the option to include
    a savings card
  • Receive alerts for annual reauthorizations
    and renewals
  • Track and monitor where patients are in the
    prescription process

 

LEARN MORE ABOUT
STREAMLINING
THE
PRESCRIPTION PROCESS
WITH COMPLETE PRO

Downloadable resources

DOWNLOAD RINVOQ
RESOURCES TO
SUPPORT
YOUR PATIENTS
AND YOUR PRACTICE

Interested to learn about safety data for RINVOQ?

See RINVOQ’s safety data across clinical trials